To determine the scope of AKT/mTOR pathway activation in vivo, we assessed the phosphorylation status of mTORC1 and mTORC2 pathway effectors in MPNST tumorgrafts by RPPA. The gene discussed is AKT1; the disease is malignant peripheral nerve sheath tumor.